Back to search
Acute Drug-induced Liver Injury
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Drug-induced Liver Injury trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Drug-induced Liver Injury trials you may qualify forDrug-induced liver injury (DILI) can lead to potentially fatal complications, such as acute liver failure and even death. In clinical practice, glucocorticoids…
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, an…
The clinical trial will assess the safety of miroliverELAP for the treatment of acute liver failure, severe acute alcohol-associated hepatitis, or acute on chro…
Prospective, single center, open label, randomized controlled trial to explore whether digoxin treatment affects cytokine levels as biomarkers of inflammation i…
Acute liver failure (ALF) is a serious condition in which the liver suddenly stops working, often leading to life-threatening complications. While N-Acetylcyste…